CIBSS - Centre for integrative Biological Signalling Studies CIBSS

PUBLICATIONS

CIBSS Publications

Publikationen filtern nach Jahr
All
2026
2025
2024
2023
2022
2021
2020
2019

Sparse dimensionality reduction for analyzing single-cell-resolved interactions

Brunn N, Hackenberg M, Fullio CL, Vogel T, Binder H.

Bioinformatics. 2024; doi: 10.1093/bioadv/vbaf230.

O-(2-[18F]fluoroethyl)-L-tyrosine-PET-guided versus contrast-enhanced T1-weighted MRI-guided re-irradiation in patients with recurrent glioblastoma (GLIAA/NOA-10 ARO2013-01): a multicentre, open-label, randomised trial.

Grosu AL, Weber WA, Graf E, Mix M, Nestle U, Schimek-Jasch T, Wiehle R, Mader I, Würtemberger U, Langen KJ, Niyazi M, Paulsen F, König L, Giordano FA, Spehl I, Bernhardt D, Schymalla MM, Pöttgen C, Semrau S, Brunner T, Hültenschmidt B, Krause BJ, Ciernik IF, Beck J, Baumert BG, Meyer PT, Urbach H, Popp I; GLIAA Study Group.

Lancet Oncol. 2026; doi: 10.1016/S1470-2045(25)00642-4.

More

IL-6 trans-signaling: an overlooked driver of retinal neovascularization?

Jung M, Ness JN, Schwämmle ME, Rapp J, Boneva S, Groß O, Mitschke J, Schlunck G, Agostini H, Hannibal L, Bucher F.

Angiogenesis. 2025; doi: 10.1007/s10456-025-10022-8

Symbiosome functionality in Medicago truncatula nodules requires continuous clearing of pectins from the symbiosome space

Gao Y, Chen L, Yang W, Yue T, Li Q, Chen K, Yuan J, Li X, Ott T, Su C

Nat Commun. 2025; doi: 10.1038/s41467-025-67404-1.

Oncostatin M induced by STAT5-activating oncogenes promotes disease progression in hematologic malignancies

Rassner M, Müller TA, Crossley KA, Andrieux G, Schaberg S, Endres C, Jakob L, Poggio T, Köhler N, Kolter J, Müller-Newen G, Schönberger K, Cabezas-Wallscheid N, Gonzalez-Menendez I, Quintanilla-Martinez L, Zwick M, Ashok D, Hartmann TN, Groß O, Gorka O, Follo M, Illert AL, Boerries M, Zeiser R, Duyster J.

Signal Transduct Target Ther. 2025; doi: 10.1038/s41392-025-02491-6

Oncostatin M induced by STAT5-activating oncogenes promotes disease progression in hematologic malignancies

Rassner M, Müller TA, Crossley KA, Andrieux G, Schaberg S, Endres C, Jakob L, Poggio T, Köhler N, Kolter J, Müller-Newen G, Schönberger K, Cabezas-Wallscheid N, Gonzalez-Menendez I, Quintanilla-Martinez L, Zwick M, Ashok D, Hartmann TN, Groß O, Gorka O, Follo M, Illert AL, Boerries M, Zeiser R, Duyster J.

Signal Transduct Target Ther. 2025; doi: 10.1038/s41392-025-02491-6.

More

Cis- and trans-binding chimeric costimulatory receptors enhance T-cell fitness and tumor control

Hernández-López P, Riillo C, Gasull-Celades L, Lommen JGE, Heijhuurs S, Zheng J, van Bruggen S, Zintchenko M, Brandl SM, Minguet S, Kuball J, Beringer DX.

Cell Mol Immunol. 2026; doi: 10.1038/s41423-025-01373-9.

FLT3-ITD Induces CMTM6 and Enhances Immune Escape in Acute Myeloid Leukemia

Zwick M, Zinkel B, Spohr C, Rückert T, Halbach S, Shoumariyeh K, Scheid J, Baur AS, Braun LM, Angel M, Michaeli E, Todkar A, Nelde A, Märklin M, Holzmayer SJ, Dicks S, Boerries M, Duquesne S, Schlaak AE, Otto-Mora P, Bengsch B, Schiff M, Kissel S, Selle M, Follo M, Altmann H, Kunadt D, Illert AL, Walz JS, Walz G, Duyster J, Schetelig J, Brummer T, Zeiser R, Köhler N.

Cancer Research. 2025, https://doi.org/10.1158/0008-5472.CAN-25-0349

More

Biological organ ages associate with risk of chronic diseases in a community-based population

Liu CS, Yeo WJ, Surapaneni A, Windham BG, Oh HS, Prizment A, Sedaghat S, Schlosser P, Rhee EP, Waikar SS, Coresh J, Walker KA, Grams ME.

JCI Insight. 2025; doi: 10.1172/jci.insight.197304.

A JAK/STAT-Pdk1-S6K axis bypasses systemic growth restrictions to promote regeneration

Vijayakumar Maya A, Neuhaus L, Nogay L, Singh A, Heckmann L, Grass I, Büscher J, Kierdorf K, Classen AK.

Nat Commun. 2025; doi: 10.1038/s41467-025-66995-z.

12345
Go to page: